Varex Imaging (VREX) Projected to Release Earnings on Tuesday

Key Points

• Varex Imaging is expected to report Q4 2026 results after market close on November 17, with analysts forecasting EPS of $0.33 and revenue of $229.79 million.
• In its most recent quarter, Varex reported EPS of $0.31, beating the $0.21 consensus, but revenue of $210.5 million fell short of estimates.
• Analysts’ consensus rating is Hold, with a $16.88 average price target; the stock opened at $18.45 in the article’s reporting.

Varex Imaging (NASDAQ:VREX - Get Free Report) is projected to announce its Q4 2026 results after the market closes on Tuesday, November 17th. Analysts expect the company to post earnings of $0.33 per share and revenue of $229.79 million for the quarter. Interested persons may visit the company's upcoming Q4 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 17, 2026 at 4:00 PM ET.

Varex Imaging (NASDAQ:VREX - Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.21 by $0.10. The business had revenue of $210.50 million during the quarter, compared to analyst estimates of $215.50 million. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. On average, analysts expect Varex Imaging to post $1.04 EPS for the current fiscal year and $1.10 EPS for the next fiscal year.

Varex Imaging Stock Performance

Varex Imaging stock opened at $18.45 on Tuesday. Varex Imaging has a fifty-two week low of $9.09 and a fifty-two week high of $18.63. The stock's 50 day simple moving average is $18.46 and its two-hundred day simple moving average is $13.76. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.53 and a current ratio of 3.38. The stock has a market cap of $783.39 million, a price-to-earnings ratio of 35.48 and a beta of 1.02.

Insider Transactions at Varex Imaging

In other Varex Imaging news, CFO Shubham Maheshwari sold 130,000 shares of the firm's stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $18.46, for a total transaction of $2,399,800.00. Following the completion of the transaction, the chief financial officer owned 139,972 shares of the company's stock, valued at approximately $2,583,883.12. This trade represents a 48.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jay Kunkel sold 8,121 shares of the firm's stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $18.48, for a total transaction of $150,076.08. Following the transaction, the director directly owned 15,329 shares of the company's stock, valued at $283,279.92. This represents a 34.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 4.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. B. Riley Financial cut Varex Imaging from a "buy" rating to a "hold" rating in a research note on Monday, August 10th. CJS Securities cut Varex Imaging from an "outperform" rating to a "market perform" rating in a research note on Monday, August 17th. Zacks Research cut Varex Imaging from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 27th. Weiss Ratings upgraded Varex Imaging from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, October 8th. Finally, Oppenheimer lowered Varex Imaging from an "outperform" rating to a "market perform" rating in a research report on Monday, August 10th. Seven investment analysts have rated the stock with a Hold rating. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $16.88.

About Varex Imaging

Varex Imaging Corporation develops and manufactures X-ray imaging components used in medical, industrial, and security applications. Its products are incorporated into systems that support diagnostic imaging, radiation therapy, baggage inspection, cargo screening, and other imaging processes.

The company's product portfolio includes X-ray tubes, digital detectors, image-processing software, high-voltage connectors, and other components for X-ray imaging systems. Varex also provides software and services designed to support image quality, system performance, and equipment integration.

Varex serves equipment manufacturers and other customers worldwide, with applications spanning healthcare, industrial inspection, and security screening.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.